Adapthealth (AHCO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access AHCO quarterly Cash Flow →
Observing cash flow movements over recent quarters helps explain how Adapthealth adapts cash usage as operating conditions change.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
12 Months
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-66.04
Depreciation & amortization381.93
Amortization of Other Assets5.69
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets to be Disposed of128.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-11.49
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business-32.60
Share-based Compensation21.88
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Investment Income Interest-
Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value Low-
Write Off Of Deferred Debt Issuance Cost-
Debt Instrument Decrease Forgiveness-
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost-
Investment Income Interest Held In Trust Account-
Operating Lease Right Of Use Asset Amortization Expense31.11
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Liability-
Increase Decrease In Operating Lease Liability-31.12
Income taxes47.16
Unrealized Gain (Loss) on Derivatives0.00
Increase (Decrease) in Accounts Receivable30.99
Increase (Decrease) in Accounts Payable and Accrued Liabilities139.27
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-61.07
Other Working Capital0.00
Other Noncash Income (Expense)2.72
Other net0.00
Payments for (Proceeds from) Other Operating Activities15.34
Discontinued operations0.00
Net Cash flow from Operating Activities601.77
Investing Activities
Capital Expenditures-382.39
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Proceeds From Contingent Consideration Receivable1.16
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired-42.38
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested120.42
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-303.19
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-250.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock-6.97
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-1.49
Cash Acquired From Acquisition Classified As Financing Activity-
Payments For Exchange Of Common Stock For Cash-
Payments For Exercise Of Call Option Relating To Put Call Agreement-
Payment Of Deferred Purchase Price In Acquisition-
Finance Lease Principal Payments-18.48
Payments For Contingent Consideration Liability And Deferred Purchase Price From Acquisitions-0.21
Payments For Tax Receivable Agreement-25.05
Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Paid0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-302.19
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow219.38
Total Cash Flow-3.61
4 historic quarters locked

Sign in to unlock the full Adapthealth cash flow history.

About Adapthealth Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: ahco-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-011213

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License